Cargando…

Efalizumab in the treatment of psoriasis

The humanized antibody efalizumab is currently the only T-cell directed biologic approved for the treatment of moderate-to-severe psoriasis by both American and European authorities. Binding to and blocking the function of the adhesion molecule leukocyte function associated antigen 1 (LFA-1), it is...

Descripción completa

Detalles Bibliográficos
Autor principal: Boehncke, Wolf-Henning
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721316/
https://www.ncbi.nlm.nih.gov/pubmed/19707339